Outcomes of Radiotherapy in the First-Line Treatment of Recurrent/Metastatic Cervical Cancer: A Multicenter, Retrospective Study

被引：0
|
作者：
Peng, C. [1 ]
Li, X. [1 ]
Tang, W. [1 ]
Guo, Q. [1 ]
Wu, Q. [1 ]
Xie, P. [1 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1086
引用
收藏
页码：S189 / S189
页数：1
相关论文
共 50 条
  • [31] Bevacizumab in first-line treatment of metastatic breast cancer
    Miles, David
    DRUGS, 2007, 67 (12) : 1800 - 1800
  • [32] Optimizing the first-line treatment for metastatic colorectal cancer
    Cherri, Sara
    Oneda, Ester
    Zanotti, Laura
    Zaniboni, Alberto
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [33] BevacizumabIn First-Line Treatment of Metastatic Breast Cancer
    Lesley J. Scott
    Drugs, 2007, 67 : 1793 - 1799
  • [34] Optimizing the first-line treatment for metastatic colorectal cancer
    Ciardiello, Davide
    Petrillo, Angelica
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [35] Bevacizumab in the first-line treatment of metastatic breast cancer
    Cameron, David
    EJC SUPPLEMENTS, 2008, 6 (06): : 21 - 28
  • [36] Bevacizumab maintenance (BM) in first line treatment for metastatic breast cancer (MBC): a multicenter retrospective observational study
    Mentuccia, L.
    Fabi, A.
    Cassano, A.
    Vici, P.
    Michelotti, A.
    Sperduti, I.
    Sarobba, G.
    Marchetti, P.
    Scognamiglio, M. T.
    Vaccaro, A.
    Rossi, E.
    Pellegrini, D.
    Nicoletta, D.
    Pellegrino, A.
    Sini, V.
    Pizzuti, L.
    Palleschi, M.
    Moscetti, L.
    Jamara, G.
    Ciancola, F.
    Gamucci, T.
    ANNALS OF ONCOLOGY, 2015, 26 : 11 - 11
  • [37] Outcomes of First-Line Treatment (FL) of Classical Hodgkin Lymphoma (cHL) in Argentina: A Real Life Multicenter Retrospective Study
    Otero, Victoria
    Valeria Mahuad, Carolina
    Korin, Laura
    Martinez, Enriqueta
    Warley, Fernando
    Garcia Rivello, Hernan
    Cristaldo, Nancy
    Kohan, Dana
    Zerga, Marta
    Martin Garate, Gonzalo
    Vicente Reparaz, Maria De Los Angeles
    Florencia Aizpurua, Maria
    Rojas Bilbao, Erica
    Cerana, Susana
    Eugenia Funes, Maria
    Plaza, Iliana
    Cecilia Foncuberta, Maria
    Vijnovich Baron, Anahi
    Cranco, Santiago
    Vitriu, Adriana
    Gomez, Mariela
    Lavalle, Justina
    Casali, Claudia
    Clavijo, Manuela
    Melillo, Luciana
    Cabral Lorenzo, Maria Cecilia
    Miroli, Augusto
    Fishman, Laura
    Pavlove, Maximiliano J.
    Miodosky, Marcela
    Cugliari, Silvana
    BLOOD, 2019, 134
  • [38] A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer
    R López
    M Salgado
    M Reboredo
    C Grande
    J C Méndez
    M Jorge
    C Romero
    G Quintero
    J de la Cámara
    S Candamio
    British Journal of Cancer, 2010, 103 : 1536 - 1541
  • [39] A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer
    Lopez, R.
    Salgado, M.
    Reboredo, M.
    Grande, C.
    Mendez, J. C.
    Jorge, M.
    Romero, C.
    Quintero, G.
    de la Camara, J.
    Candamio, S.
    BRITISH JOURNAL OF CANCER, 2010, 103 (10) : 1536 - 1541
  • [40] Is the use of cetuximab in the first-line treatment of recurrent/metastatic head and neck cancer still important?
    Vitale, Pasquale
    De Falco, Vincenzo
    Addeo, Raffaele
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (07) : 481 - 484
12345